The present invention is directed to novel substituted aminopiperidines which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DPP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
本发明涉及一种新型的取代
氨基
哌啶,它是二肽基肽酶-IV酶(“
DPP-IV酶”)的
抑制剂,并且在治疗或预防
DPP-IV酶参与的疾病,如糖尿病,尤其是2型糖尿病方面具有用处。本发明还涉及包含这些化合物的制药组合物,以及使用这些化合物和组合物在预防或治疗
DPP-IV酶参与的这些疾病方面的用途。